Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Prothena Corp Q4 2023 GAAP EPS $(1.26) Misses $(1.22) Estimate, Sales $316.00K Miss $2.15M Estimate

Author: Benzinga Newsdesk | February 15, 2024 05:10pm
Prothena Corp (NASDAQ:PRTA) reported quarterly losses of $(1.26) per share which missed the analyst consensus estimate of $(1.22) by 3.28 percent. This is a 1150 percent decrease over earnings of $0.12 per share from the same period last year. The company reported quarterly sales of $316.00 thousand which missed the analyst consensus estimate of $2.15 million by 85.32 percent. This is a 99.37 percent decrease over sales of $49.92 million the same period last year.

Posted In: PRTA


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist